reslizumab (Cinqair)

Original post, click here

Generic Name: reslizumab

Brand Name: Cinqair

Manufacturer: TEVA Canada Innovation

Indications: Asthma, eosinophilic

Manufacturer Requested Reimbursement Criteria1: Not applicable

Submission Type: Request For Advice

Project Status: Received

Biosimilar: No

  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.

Submit Feedback